Literature DB >> 10496841

Low molecular weight heparins could be important in cancer.

S Siragusa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10496841      PMCID： PMC1116675     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Antithrombotic therapy in cancer.

Authors:  A K Kakkar; R C Williamson
Journal:  BMJ       Date:  1999-06-12

2.  Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin.

Authors:  D Green; R D Hull; R Brant; G F Pineo
Journal:  Lancet       Date:  1992-06-13       Impact factor: 79.321

3.  Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis.

Authors:  S Siragusa; B Cosmi; F Piovella; J Hirsh; J S Ginsberg
Journal:  Am J Med       Date:  1996-03       Impact factor: 4.965
  3 in total
  1 in total

Review 1.  Parenteral anticoagulation in ambulatory patients with cancer.

Authors:  Elie A Akl; Lara A Kahale; Maram B Hakoum; Charbel F Matar; Francesca Sperati; Maddalena Barba; Victor E D Yosuico; Irene Terrenato; Anneliese Synnot; Holger Schünemann
Journal:  Cochrane Database Syst Rev       Date:  2017-09-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.